ViroGates A/S Logo

ViroGates A/S

Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.

VIRO | ST

Overview

Corporate Details

ISIN(s):
DK0061030574
LEI:
5493007TX8XS56RMZD94
Country:
Denmark
Address:
Banevænget 13 1., 3460 Birkerød
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ViroGates A/S is an international medical technology company that develops and markets in vitro diagnostic blood tests for measuring chronic inflammation. Founded in 2000, its core technology is centered on the prognostic biomarker suPAR (soluble urokinase Plasminogen Activator Receptor). The company's products are sold under the suPARnostic® brand and are used for health risk assessment and to support clinical decision-making. Key markets include acute care, where the tests enhance patient triage and risk stratification; longevity, for assessing inflammation-driven aging and guiding personalized preventative care; and clinical research, to optimize patient selection and monitor intervention outcomes. The suPARnostic® product suite includes the Quick Triage point-of-care test, the Turbi-Latex solution for automated systems, and an ELISA assay for clinical and research applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-17 11:01
Earnings Release
English 134.5 KB
2024-12-17 11:01
Regulatory News Service
Danish 429.4 KB

Automate Your Workflow. Get a real-time feed of all ViroGates A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ViroGates A/S

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ViroGates A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.